STAT4d
The abrupt end of USAID-funded clinical trials is profoundly unethical
USAID's stop-work order threatens to undo decades of progress in medical research ethics and cause harm to clinical trial ...
How Can Clinical Trials Improve Diversity? CTM’s Cara Brant Explains
Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...
The American Journal of Managed Care1d
Clinical Trials Must Represent Those Who Will Receive Therapy
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
US FDA drops web pages on improving clinical trial diversity
The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and devices in diverse populations as part of a purge of diversity, equity and ...
MMJ Marijuana Waiting FDA Approved Huntington's Clinical Trials As RFK Jr.'s Push to Conduct Scientific Research
MMJ's innovative soft gelatin THC-CBD capsule, known as MMJ-002, is undergoing the rigorous FDA approval process to ...
Managed Healthcare Executive11h
FDA, EMA See Differences in Cell and Gene Therapy Trial Data
Researchers have suggested that uniform evidence standards and reporting requirements could help speed patient access to cell and gene therapies and help ensure consistent safety and efficacy ...
PharmaTimes29d
Zydus announces USFDA Orphan Drug Designation for Usnoflast in ALS treatment
Zydus has previously completed a Phase 2(a) clinical trial in 24 ALS patients in India. Zydus has also received approval from the USFDA to initiate a Phase 2(b) clinical trial for Usnoflast in ALS ...